Search

You searched for "obstructive"

540 results found

SMILE: sustaining medical education in a lockdown environment

3 February 2021 | | URO - Core Urology
2020 posed challenges to medical education like never seen before. In an effort to contain and slow the spread of coronavirus all UK medical schools ceased or reduced face-to-face contact. This sudden, and for many, unexpected change resulted in pressures...

Activity of enzalutamide in men with mCRPC is affected by prior treatment with abiraterone and / or docetaxel

1 September 2015 | | URO - Urologic Oncology
This study reported on the real-world clinical outcomes of patients at seven academic institutions who were treated with enzalutamide, with the primary objective being to assess the effect of prior therapies (namely abireterone and docetaxel). Three hundred and ten patients...

Utility of biomarkers in the prediction of oncologic outcome after radical cystectomy for SCC

1 July 2015 | | URO - Basic Science Research
Squamous cell carcinoma (SCC) of the bladder is more commonly seen in Egypt due to schistosomiasis (bilharziasis) and accounts for 2% to 5% of all bladder tumours. Schistosomiasis is found in the bladder vasculature and leads to chronic inflammation causing...

Viveca Biomed acquires Contrelle Activgard – European market launch imminent!

5 November 2019 | Research & Development
Viveca Biomed is pleased to announce the imminent relaunch of Contrelle Activgard across Europe, starting with the UK market.

Minze Uroflow System

2 March 2022 | Research & Development
Minze Uroflow System with Bluetooth makes it possible for men, women and children with LUTs and bladder dysfunction to be assessed, diagnosed and monitored remotely in the comfort of their homes.

Minze Homeflow – uroflowmeter with automated bladder diary usable on any toilet!

1 January 0001 | Contracts & Distributors, Research & Development
Minze Homeflow makes it possible for men, women and children with LUTs and bladder dysfunction to be assessed, diagnosed, treated and monitored remotely in the comfort of their homes.

Prostate Scotland appoints digital technology leader Peter Proud as new trustee

16 December 2025
Prostate Scotland has appointed Peter Proud, Founder and CEO of Edinburgh-based digital technology company Forrit, to its Board of Trustees. Bringing more than 30 years of experience in digital transformation, data, and AI-driven innovation, Peter will support the charity’s work...

Evelina Paediatric Urodynamics Course 2025

5 June 2025 -6 June 2025
This two day face to face course will start by covering normal childhood bladder and bowel anatomy and function along with an outline of Bladder Bowel dysfunction (BBD). The bulk of the course will cover urodynamic assessment of BBD both with non-invasive strategies such as Diaries, Uroflowmetry (together with use of EMG) and ultrasound scanning, and invasive urodynamics to include videourodynamics and ambulatory urodynamics. Practical demonstration along with work-shop scenarios will be provided along with case studies. We will not concentrate much on treatment but will provide demonstration of superficial neuromodulation such as TENS and the principles/practice of Biofeedback treatment.

Sustainable healthcare: what steps can urologists take?

3 November 2022 |
Human health is intrinsically linked to environmental health, making the ever-pressing climate crisis fundamentally a public health emergency. The healthcare sector is responsible for 8% of the UK’s greenhouse gas (GHG) emissions worldwide [1]. As the largest publicly funded healthcare...

Urinary biomarkers for surveillance of non-muscle invasive bladder cancer

1 May 2019 | | URO - Basic Science Research, URO - Urologic Oncology
Bladder cancer (BC) is the ninth most common cancer worldwide with a yearly incidence of approximately 430,000 cases. There is a male predominance and it is the seventh most common cancer in men worldwide [1]. Non-muscle invasive bladder cancer (NMIBC)...

Recent developments in bladder cancer – NMIBC

3 May 2022 | | URO - Urologic Oncology
Every year, roughly 10,300 individuals are diagnosed with bladder cancer in the UK, making it the 11th most common cancer in the UK, and the eighth most common cancer in men [1]. Of those diagnosed with the disease, 75-85% will...

Moving hospitals as a consultant urological surgeon: what are the challenges?

2 March 2022 |
Despite over 100 unfilled consultant urological surgeon posts in the UK, the reasons why an established surgeon should wish to move hospitals can still be viewed with suspicion. Why is this the case, when in many other careers, both within...